Dear Editor,
Decision to withhold or withdraw life-sustaining supports is a worldwide practice in intensive care units (ICUs) [1]. In France, these decisions are made by medical and non-medical teams during limitation life-sustaining support (LLSS) meetings according to the French legislation [2]. Previous studies have reported that over half of deaths in French ICUs occurred after a decision to withhold or withdraw treatment taken during these meetings [3]. Moreover, to date most studies [4, 5] report a lack of clarity on the modalities of the process. Our work aimed to highlight the main arguments influencing decisions during LLSS meetings and to analyze the reality of the interprofessional approach to these decisions.
This is a multicenter, observational study involving all participants of randomly screened LLSS meetings, consecutively in University Hospitals (UH) of Besançon, Dijon and Cayenne General Hospital, from August 2, 2021 to February 2, 2022. Non opposition of participants and patients (or their next of kin when appropriate) to audio recordings was checked prior to inclusion. Only one LLSS meeting per patient was eligible for inclusion. Data were collected through a non-participatory observational method by audio recording and real-time note-taking.
We conducted a mixt qualitative and quantitative analysis. Audio recorded meetings were transcribed, and analyzed according to a thematic “Framework Method”. Recruitment was closed when theoretical saturation was reached. Measurement of speaking time was calculated after each meeting from the audio recordings. The quantitative approach aimed to present collected data in a statistical model. Finally, potential links between the qualitative and quantitative approaches were investigated.
Overall, 15 LLSS meetings (7 withholding life support, 6 withdrawal life support, and, 2 postponed decisions) involving 122 participants (33 physicians, 31 junior doctors, 28 paramedics, 2 psychologists, and 28 students) were included. Patients’ characteristics are provided in the online Supplement (supplementary material 1). Only one patient was able to speak for himself, and 10/15 patients (66.7%) had relatives in their entourage to express their wishes. No patient had expressed advance directives.
Five main themes emerged from the audio recordings analysis: medical references, specific patients’ characteristics, involvement of relatives, the physicians’ subjectivity and temporality of events (Fig. 1A).
Fig. 1.
Overview of the decision-making process of LSST meetings. The five main themes and sub-themes that emerged (A) and the effective exchange time allocation according to participants’ status (B). Values are expressed as mean ± standard deviation or percentage of the total exchange time. Effective exchange time refers to speaking time after patient presentation (min). Paramedics represent ICU nurses and health care assistants; other participants are psychologists, medical students or students in nursing care
On average, 10 ± 2 participants including 4 ± 1 physicians were present at each meeting. Meetings lasted between 10 and 42 min (20 ± 10) and about one third of the speaking time was devoted to the presentation of the patient. Of the effective exchange time (14 ± 10), speaking time was mainly allocated to intensivists (70 ± 15%) (Fig. 1B).
As this study was conducted during the SARS-CoV-2 pandemic crisis, we cannot ignore the bias associated with the increased work load and distress experienced by caregivers during this period.
In conclusion, our study suggests that decision-making process during LLSS meetings is not based exclusively on the patient’s medical parameters, but also, on the involvement of relatives, temporality of events and on physicians’ subjectivity. Concurrently, even if legal standards were met, the emergence of a genuine interdisciplinary process was missing during LLSS discussions. Enhancing the quality of deliberation in these meetings could be a major axis of improvement to optimize the process.
Supplementary Information
Below is the link to the electronic supplementary material.
Acknowledgements
We acknowledge Aurelie Marceau, MD, Aline Chassagne, Florence Mathieu-Nicot, Alain Togneri, MD, Emmanuel Samain, Ph.D. for their substantial contributions to the different steps of the implementation of this study; and anonymous reviewers who provided suggestions that improved the interpretation and presentation of the study. The REUREA Study Group: Régis Aubry, Guillaume Besch, Laurent Carteron, Mathilde Giffard, Hatem Kallel, Séverine Matheus, Gael Piton, Jean Marc Pujo, Jean-Pierre Quenot, Terry Tarcy, Hadrien Winiszewski.
Author contributions
RA, MG, SM and HK commented and corrected the first versions of the manuscript. MG was the co-investigator who enabled the objectivity of the data analysis. SM contributed to the creation of table 1. HK proofread and corrected the whole manuscript, he optimized tables 1 to 4. GB corrected and improved the manuscript’s design. All authors from REUREA Study group critically revised the manuscript and have read and approved the final version.
Funding
This study received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Declarations
Ethics statement
The study and its protocols were approved by the Ethics Committee of the French Society of Anesthesia and Intensive Care (SFAR) (no. IRB 00010254-2021-136; chairperson: Dr PJ Zetlaoui), on June 29, 2021.
Conflict of interest
The author declares no conflict of interest
Footnotes
The members of the The REUREA Study Group are listed in Acknowledgements.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Terry Tarcy, Email: tevarot@gmail.com.
REUREA Study Group:
Régis Aubry, Guillaume Besch, Laurent Carteron, Mathilde Giffard, Hatem Kallel, Séverine Matheus, Gael Piton, Jean Marc Pujo, Jean-Pierre Quenot, Terry Tarcy, and Hadrien Winiszewski
References
- 1.Sprung CL, Truog RD, Curtis JR, et al. Seeking worldwide professional consensus on the principles of end-of-life care for the critically ill. The consensus for worldwide end-of-life practice for patients in intensive care units (WELPICUS) Study. Am J Respir Crit Care Med. 2014;190:855–866. doi: 10.1164/rccm.201403-0593CC. [DOI] [PubMed] [Google Scholar]
- 2.(2016) LOI n° 2016-87 du 2 février 2016 créant de nouveaux droits en faveur des malades et des personnes en fin de vie (1) [PubMed]
- 3.Lesieur O, Leloup M, Gonzalez F, et al. Withholding or withdrawal of treatment under French rules: a study performed in 43 intensive care units. Ann Intensive Care. 2015;5:15. doi: 10.1186/s13613-015-0056-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Quenot J-P, Ecarnot F, Meunier-Beillard N, et al. What are the ethical aspects surrounding the collegial decisional process in limiting and withdrawing treatment in intensive care? Ann Transl Med. 2017;5:S43. doi: 10.21037/atm.2017.04.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Curtis JR, Vincent J-L. Ethics and end-of-life care for adults in the intensive care unit. Lancet. 2010;376:1347–1353. doi: 10.1016/S0140-6736(10)60143-2. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

